US Stock MarketDetailed Quotes

IMUX Immunic

Watchlist
  • 1.050
  • -0.020-1.87%
Trading May 7 12:00 ET
100.61MMarket Cap-1.05P/E (TTM)

About Immunic Company

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis. The firm’s products include IMU-838, IMU-935, and IMU-856. The company was founded in May 2003 and is headquartered in New York, NY.

Company Profile

SymbolIMUX
Company NameImmunic
Listing DateApr 17, 2014
Issue Price12.00
Founded2003
CEODr. Daniel Vitt, PhD
MarketNASDAQ
Employees77
Fiscal Year Ends12-31
Address1200 Avenue of the Americas,Suite 200
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10036
Phone1-332-255-9818
Websitehttp://imux.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Daniel Vitt, PhD
  • Director and Chief Executive Officer
  • 2.94M
  • Werner Gladdines
  • Chief Development Officer
  • --
  • Patrick Walsh
  • Chief Business Officer
  • --
  • Jason Tardio, M.B.A.
  • Chief Operating Officer and President
  • 1.03M
  • Glenn Whaley
  • Chief Financial Officer and Principal Accounting Officer
  • 1.17M
  • Dr. Hella Kohlhof
  • Chief Scientific Officer
  • --
  • Dr. Andreas Muehler
  • Chief Medical Officer
  • 1.37M
  • Dr. Duane D. Nash, M.D.
  • Executive Chairman of the Board
  • 1.21M
  • Simona Skerjanec, M.B.A.
  • Director
  • 193.14K
  • Tamar D. Howson
  • Independent Director
  • 176.74K
  • Monika Maria Tornsen
  • Independent Director
  • 158.39K
  • Richard Alan Rudick
  • Independent Director
  • 148.90K
  • Barclay A. Phillips
  • Lead Independent Director
  • 196.00K
  • Dr. Jorg Neermann, PhD
  • Independent Director
  • 185.28K
  • Inderpal Singh
  • General Counsel
  • --

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Halozyme Therapeutics
HALO
68.470
YETI Holdings
YETI
27.790
DexCom
DXCM
82.430
4
Constellation Brands
STZ
189.035
5
Enerpac Tool
EPAC
41.970
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.